A rare case report: chronic generalized idiopathic pruritus.

IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL AME Case Reports Pub Date : 2023-10-11 eCollection Date: 2023-01-01 DOI:10.21037/acr-23-40
Iya Agha, Emmanuel Khodra, Ryan Cornell, Jaskaran Ghotra, Noor Asif, Saif Aldeen Agha, Ayad K M Agha
{"title":"A rare case report: chronic generalized idiopathic pruritus.","authors":"Iya Agha, Emmanuel Khodra, Ryan Cornell, Jaskaran Ghotra, Noor Asif, Saif Aldeen Agha, Ayad K M Agha","doi":"10.21037/acr-23-40","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Generalized chronic pruritus (CP) can be associated with seborrheic dermatitis and psoriasis but often can present without any noticeable diagnosis or obvious skin lesion. When not related to a clear diagnosis, CP can be characterized as idiopathic pruritus. CP is both a diagnostically and therapeutically challenging presentation due to the variety of systemic, dermatological, neurological, and psychogenic diseases that must be ruled out before diagnosing idiopathic pruritus. This presentation is often overlooked but can lead to a greatly diminished quality of life for patients who present with idiopathic generalized pruritus. The course of treatment will vary between providers and specialties, however, most dermatologists will attempt control with antihistamines, topical steroids, or oral steroids. The use of gabapentinoids for the treatment of CP is understudied. Gabapentin was initially developed as an antiepileptic that has since been approved to treat neuropathic pain and has a common off-label use in dermatology and can be used to effectively treat CP.</p><p><strong>Case description: </strong>Here we present a case of a 56-year-old Caucasian male who presented to the outpatient dermatology clinic with new-onset, diffuse, and intense pruritic symptoms that gradually progressed over a period of seven weeks. This case study details a patient with Idiopathic generalized pruritus previously uncontrolled that was well-controlled with the use of gabapentin after trials of other common treatments failed.</p><p><strong>Conclusions: </strong>The understudied off-label use of gabapentin in the case of generalized chronic idiopathic pruritus should be explored and later implemented as a mainstay for patients suffering from uncontrolled CP as it was shown to completely eliminate pruritic symptoms and improve the quality of life for this patient.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"7 ","pages":"45"},"PeriodicalIF":0.7000,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628390/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AME Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/acr-23-40","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Generalized chronic pruritus (CP) can be associated with seborrheic dermatitis and psoriasis but often can present without any noticeable diagnosis or obvious skin lesion. When not related to a clear diagnosis, CP can be characterized as idiopathic pruritus. CP is both a diagnostically and therapeutically challenging presentation due to the variety of systemic, dermatological, neurological, and psychogenic diseases that must be ruled out before diagnosing idiopathic pruritus. This presentation is often overlooked but can lead to a greatly diminished quality of life for patients who present with idiopathic generalized pruritus. The course of treatment will vary between providers and specialties, however, most dermatologists will attempt control with antihistamines, topical steroids, or oral steroids. The use of gabapentinoids for the treatment of CP is understudied. Gabapentin was initially developed as an antiepileptic that has since been approved to treat neuropathic pain and has a common off-label use in dermatology and can be used to effectively treat CP.

Case description: Here we present a case of a 56-year-old Caucasian male who presented to the outpatient dermatology clinic with new-onset, diffuse, and intense pruritic symptoms that gradually progressed over a period of seven weeks. This case study details a patient with Idiopathic generalized pruritus previously uncontrolled that was well-controlled with the use of gabapentin after trials of other common treatments failed.

Conclusions: The understudied off-label use of gabapentin in the case of generalized chronic idiopathic pruritus should be explored and later implemented as a mainstay for patients suffering from uncontrolled CP as it was shown to completely eliminate pruritic symptoms and improve the quality of life for this patient.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
罕见病例报告:慢性全身性特发性瘙痒症。
背景:全身性慢性瘙痒症(CP)可能与脂溢性皮炎和银屑病有关,但通常没有任何明显的诊断或明显的皮肤损伤。当与明确诊断无关时,CP可被定性为特发性瘙痒症。CP在诊断和治疗上都具有挑战性,因为在诊断特发性瘙痒症之前,必须排除各种系统性、皮肤病、神经性和心因性疾病。这种表现经常被忽视,但可能导致特发性全身瘙痒症患者的生活质量大大降低。治疗过程因提供者和专业而异,然而,大多数皮肤科医生会尝试用抗组胺药、局部类固醇或口服类固醇进行控制。加巴喷丁类药物用于治疗CP的研究不足。加巴喷丁最初被开发为一种抗癫痫药物,后来被批准用于治疗神经性疼痛,在皮肤科有一种常见的标签外用途,可用于有效治疗CP。病例描述:我们报告了一例56岁的白人男性,他在皮肤科门诊就诊时出现新发、弥漫性,以及在七周内逐渐发展的强烈瘙痒症状。本病例研究详细介绍了一名特发性全身性瘙痒症患者,在其他常见治疗方法的试验失败后,加巴喷丁的使用很好地控制了该患者。结论:加巴喷丁在全身性慢性特发性瘙痒症患者中的标示外使用研究不足,应进行探索,并在以后作为不受控制的CP患者的支柱实施,因为它已被证明可以完全消除瘙痒症状,提高患者的生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Collision tumor of the cecum and ileocecal valve composed of mucinous adenocarcinoma and neuroendocrine tumor: a case report. Trans-septal left ventricular endocardial lead in a patient with extensive anterior myocardial infarction and left ventricle (LV) apical endoventriculoplasty using a Vascutek patch-case report. Isolated central nervous system (CNS) relapse of multiple myeloma 11 years after autologous stem cell transplantation: a case report. Suspected local anesthetic resistance after intrathecal, perineural, intraarticular and subcutaneous injections: a case report. Medial collateral ligament section during unicompartmental knee arthroplasty managed by direct repair and fascia lata augmentation autograft: a case report and surgical technique.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1